Financial statements Podopharm Jakub Oleszek
Balance sheet of Podopharm Jakub Oleszek
Company age:
Age:
6 y. 2 d.
Balance sheet data of PODOPHARM JAKUB OLESZEK
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 4 391 887,43 | 4 821 840,88 | 7 000 796,36 | 15 264 678,71 |
| A. Fixed assets | 572 193,38 | 605 243,38 | 3 931 134,56 | 12 216 310,11 |
| B. Current assets | 3 819 694,05 | 4 216 597,50 | 3 069 661,80 | 3 048 368,60 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 4 391 887,43 | 4 821 840,88 | 7 000 796,36 | 15 264 678,71 |
| A. Equity | 2 872 520,27 | 3 693 918,74 | 5 204 679,85 | 9 355 436,30 |
| B. Liabilities and provisions for liabilities | 1 519 367,16 | 1 127 922,14 | 1 796 116,51 | 5 909 242,41 |
| I. Long-term liabilities | - | - | - | 2 602 594,25 |
| II. Short-term liabilities | - | - | - | 3 281 246,40 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.